Euphomilone A
Euphomilone A is an ent-abietane-type diterpenoid osteoclastogenesis inhibitor and RANK inhibitor, found in the aerial parts of Euphorbia milii, possessing a 7/5/6 tricyclic system. Euphomilone A inhibits RANKL-induced osteoclastogenesis in monocyte/macrophage lineage cells. Euphomilone A can be used in research on bone resorption-related diseases.
For research use only. We do not sell to patients.
- CAS No.: 2077182-79-5
- Formula: C20H32O3
- Molecular Weight:320.47
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| RAW264.7 | IC50 |
12.6 μM
|
Inhibition of RANKL-induced osteoclast formation in RAW 264.7 cells.
Inhibition of RANKL-induced osteoclast formation in RAW 264.7 cells.
|
acs.orglett.6b03142 |
In Vitro
Euphomilone A inhibits RANKL-induced osteoclast formation in RAW 264.7 cells with an IC50 of 12.6 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 2077182-79-5
-
Molecular Weight 320.47
-
Formula C20H32O3
-
SMILES
C[C@@]12[C@@]3([C@@](C(C(C)([C@@H](CC3)O)C)=O)([H])C[C@@]1([H])C[C@](C)(CC2)C=C)O
-
Structure Classification
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Osteoclast differentiation from monocyte/macrophage precursors
Osteoclast differentiation is an in vitro induction assay in which monocyte/macrophage-lineage precursors are exposed to macrophage colony-stimulating factor (M-CSF) and receptor activator of NF-κB ligand (RANKL), generating multinucleated osteoclasts that are commonly identified by tartrate-resistant acid phosphatase (TRAP) staining and functionally confirmed by resorption pits on dentin, bone, or mineralized substrates. M-CSF supports survival and expansion of osteoclast precursors, while RANKL binding to RANK drives osteoclast commitment, fusion, maturation, and resorptive function; osteoprotegerin inhibits this pathway by binding RANKL and preventing RANK activation. The main readouts are the number of TRAP-positive multinucleated cells, formation of F-actin rings, and resorbed surface area; TRAP-positive multinucleated cells indicate osteoclast differentiation, whereas pit formation on dentin, bone, or mineralized coating indicates functional bone-resorbing activity.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Euphomilone A Related Classifications
HY-N21565 Related Classifications
Powered by Bioz